Collectively, these results indicate that the inhibition of intestinal FXR signaling by non-12-OH FXR-antagonistic BAs is critically involved in the regulation of GLP-1 production, insulin secretion, and glucose homeostasis by T3
Oral semaglutide: completely different rules If you are using oral semaglutide rather than injectable, the timing rules change dramatically
Safety Considerations Common Side Effects Nausea, vomiting, diarrhea, decreased appetite, constipation, and abdominal pain Injection site reactions (redness, itching, swelling) Hypoglycemia (especially if used with insulin or sulfonylureas) Serious Risks Pancreatitis: Seek immediate medical attention for severe abdominal pain
More on Ozempic: Joe Biden and Bernie Sanders Demands Drug Companies Cut Price of Ozempic and Other New Weight Loss Drugs